Newborn Kit to Save Lives and Brains in Kenya
NCT02208960 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2294
Last updated 2016-07-14
Summary
Each year, more than 3 million neonatal deaths occur worldwide and greater than 200 million children under the age of 5, almost all in low- and middle-income countries, are not fulfilling their developmental potential. The development of the growing brain can be affected through multiple mechanisms including the same insults that are major causes of mortality, namely hypothermia and infection. The first month of life is a crucial period in neurodevelopment (ND). In this study, the investigators propose the home-based use of an integrated evidence-based toolkit to improve health status, reduce the incidence of neonatal insults that may affect brain development, decrease neonatal mortality rate (NMR), and provide early identification of danger signs. The investigators hypothesize that use of the neonatal toolkit will result in an improvement of at least one standard deviation in neurodevelopment as measured at 12 months of age by the Protocol for Child Monitoring Infant and Toddler (PCM-IT) version.
Conditions
- Neurodevelopment
- Neonatal Mortality
Interventions
- DEVICE
-
Neonatal Kit
Contents of the neonatal kit: 1. Clean birth kit: sterile blade, a clean plastic square, plastic gloves, hand soap, and cord ties/clamp. 2. 4% Chlorhexidine (CHX) lotion (15 mL) and a bag of cotton balls. 3. Sunflower oil emollient (50 mL) 4. ThermoSpot 5. Mylar infant sleeve 6. Click to heat warmer (http://www.heatinaclick.ca/products/pocket\_size.html) in a fitted cloth pouch. 7. Handheld battery-operated scale with suspended cloth sling. The scale will not be included with the kit but rather one will be issued to each Community Health Worker.
- BEHAVIORAL
-
Neonatal Stimulation
A sub-set of children in the study will receive a neonatal stimulation program either on its own or in combination with the neonatal kit described above. The stimulation program will focus on teaching three key messages to enhance the caregivers' current caregiving practices, and each message is to be integrated into daily activities (e.g. during feeding, bathing, bedtime routines). By integrating the delivery of the interventions into the caregivers' daily routine, no additional time inconvenience will be added to their schedules. The key messages include: 1. Eye contact and talking to children 2. Responsive feeding and caregiving 3. Singing songs, including those with gentle touch
Sponsors & Collaborators
-
Grand Challenges Canada
collaborator OTHER -
March of Dimes
collaborator OTHER -
Aga Khan University
collaborator OTHER -
The Hospital for Sick Children
lead OTHER
Principal Investigators
-
Shaun K Morris, MD, MPH · The Hospital for Sick Children
-
Robert Armstrong · Aga Khan University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- FACTORIAL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2016-04-30
- Completion
- 2016-04-30
Countries
- Kenya
Study Locations
More Related Trials
-
Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth
NCT02071394 ·Status: COMPLETED ·Phase: PHASE2
-
Hypothermia Therapy in Pediatric Cardiac Intensive Care Unit for Suspected for Brain Injury
NCT02395276 ·Status: UNKNOWN ·Phase: NA
-
A Study of a Blood Marker in Newborns With Brain Injury Caused by Lack of Oxygen at Birth
NCT07292220 ·Status: NOT_YET_RECRUITING
-
Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
NCT05395195 ·Status: RECRUITING ·Phase: PHASE3
-
Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells
NCT02881970 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Cooling in Mild Encephalopathy
NCT05889507 ·Status: RECRUITING ·Phase: PHASE3
-
Correlation of Risk Factors and Severity of Hypoxic-ischaemic Encephalopathy
NCT02800018 ·Status: COMPLETED
-
Hypothermia During ECMO to Decrease Brain Injury
NCT01675388 ·Status: WITHDRAWN ·Phase: NA
-
Hyperbaric Oxygen Therapy Improves Outcome of Hypoxic-Ischemic Encephalopathy
NCT02894866 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers for Detection of Brain Ischemia
NCT00490295 ·Status: COMPLETED
-
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
NCT00513240 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
NCT01913340 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Brain Imaging and Developmental Follow up of Infants Treated With Erythropoietin
NCT01207778 ·Status: COMPLETED
-
Safety and Efficacy of Hypothermia to Treat Neonatal Hypoxic-Ischemic Encephalopathy
NCT00890409 ·Status: COMPLETED ·Phase: PHASE3
-
Moderate Hypothermia in Neonatal Hypoxic Ischemic Encephalopathy
NCT02826941 ·Status: COMPLETED ·Phase: PHASE2
-
Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy
NCT02455830 ·Status: UNKNOWN
-
Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy
NCT02256618 ·Status: COMPLETED ·Phase: PHASE1
-
Amnioinfusion for Intrauterine Neuroprotection
NCT05513690 ·Status: UNKNOWN ·Phase: NA
-
Neuroprotective Role of Erythropoietin in Perinatal Asphyxia
NCT02002039 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Melatonin for Neuroprotection Following Perinatal Asphyxia
NCT02071160 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pilot Study of Head Cooling in Preterm Infants With Hypoxic Ischemic Encephalopathy
NCT00620711 ·Status: COMPLETED ·Phase: PHASE1
-
MRI Thermal Imaging of Infants Undergoing Cooling for Hypoxic Ischemic Encephalopathy(HIE)
NCT01128673 ·Status: WITHDRAWN
-
Metformin Treatment in Infants After Perinatal Brain Injury
NCT05590676 ·Status: TERMINATED ·Phase: PHASE1
-
Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy
NCT00808704 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (Control Levels)
NCT02349672 ·Status: COMPLETED